PERSPECTA

News from every angle

Back to headlines

FDA Fast-Tracks Breakthrough Oral Drug for Pancreatic Cancer That Doubles Survival Rates

The US Food and Drug Administration has granted accelerated approval to a new tablet therapy capable of extending life by up to two times for patients with advanced pancreatic cancer.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.